SQUAWK/NEWS
Account
Theme
Account
Menu
Live News EQUITY ARTICLE M impact

LENZ Therapeutics Reports Quarterly Results for Quarter Ended September 30

LENZ Therapeutics reported results for the quarter ended September 30.

LENZ
SquawkNews Desk

FORECAST CHANGESRECOMMENDATIONSThis summary was machine generated from LSEG data October 29 at 12:00 p.m. UTC. ​All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com.

For any other questions or feedback, contact Refi…

Related stories

Afaq Holding reports Q3 loss of 328,057 dinars M impact | EQUITY | Oct 29, 2026, 02:41 PM UTC Teladoc Health Reports Q3 Revenue of $605.1M, Loss Narrows Third-quarter revenue fell 3.4% year over year to $605.1 million. Net loss narrowed to $26.93 million from $49.51 million, while diluted loss per share was $0.15 versus $0.28 a yea M impact | EQUITY | Oct 29, 2026, 02:41 PM UTC Klabin Sees El Niño Pressuring Operations Through Q1 2027 Klabin sees El Niño pressuring its operations through the first quarter of 2027. L impact | EQUITY | Oct 29, 2026, 02:41 PM UTC Garrett Motion shares rise 5.2% after Q3 earnings Garrett Motion shares rose 5.2% in Thursday trading after the company reported Q3 earnings and higher net sales. M impact | EQUITY | Oct 29, 2026, 02:40 PM UTC Nextensa Sells Luxembourg Office Building for EUR43.5 Million Nextensa announced the sale of a Luxembourg office building to Centre Hospitalier de Luxembourg for EUR43.5 million. L impact | EQUITY | Oct 29, 2026, 02:40 PM UTC Shenzhen Longsys Electronics Reports Quarterly Revenue of RMB 14.63 Billion M impact | EQUITY | Oct 29, 2026, 02:39 PM UTC